Correlation between COVID-19 case fatality rate and percentage of BCG vaccination: is it true the vaccine is protective? release_gud5z3cp4vc3jpmgaibdmtpbkm

by Aliae Hussein, Marwa Rashad Salem, Samar Salman, A F Abdulrahim, Nasrallah A. Al Massry, Mahmoud Saad, Nesrine Ben Hadj Dahman, Ahmed Negida

Published in Egyptian Journal of Bronchology by Springer Science and Business Media LLC.

2020   Volume 14

Abstract

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> The observations of some recent epidemiological studies offer hope for a reduced impact of COVID-19 for countries which practice universal BCG vaccination policy. </jats:sec> <jats:sec> <jats:title>Main body</jats:title> This report provides a correlation between the case fatality rates of COVID-19 and the percentage of BCG vaccination coverage in 183 most affected countries. The main objective of this observational ecologic report is to evaluate possible effects of the previous BCG vaccination in different populations and the epidemic outcomes specially the rates of severe/critical cases and case fatalities. The analysis is preliminary since it is based on constantly rolling data while the COVID-19 pandemic is still unfolding. </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> Our findings seem to support the fact that an older BCG vaccine may have a protective role in avoiding severe/critical SARS-CoV2 pneumonia and relatively decrease its fatalities. </jats:sec>
In application/xml+jats format

Archived Files and Locations

application/pdf  2.5 MB
file_5w7s7iy7gbesjhjmzdw57aggnu
ejb.springeropen.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2020-09-09
Language   en ?
Journal Metadata
Open Access Publication
In DOAJ
In Keepers Registry
ISSN-L:  1687-8426
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 1dd0a24e-5698-417e-8b75-d5df11abd421
API URL: JSON